FDA gives greenlight to new AI tool for managing heart failure patients

Marketplace

Please login to access the CRTOnline.

FDA gives greenlight to new AI tool for managing heart failure patients

The U.S. Food and Drug Administration (FDA) has officially signed off on a new artificial intelligence (AI) tool to better track heart failure from Chicago-based Cardiosense.

Transcatheter Aortic Valve-in-Mechanical Valve Replacement: A First-in-Human Study

T-TEER Device Entrapment on a Right Ventricular Pacing Lead

New Guidelines Outline Management Strategies for Cardiovascular-Kidney-Metabolic Syndrome

Reperfusion-Guided BP Targets Improve Outcomes After Stroke Thrombectomy: HOPE Trial

Prehospital Heparin Administration in Patients With STEMI Undergoing Primary PCI: HEPARIN-STEMI Randomized Controlled Trial

Patients With vs Without MS Have Similar Complication, Death Rates After Cardiac Surgery: U.S. Study

Multimodality Imaging-Guided Aspiration of a Right Ventricular Mass – Cardiac Metastasis Unmasked: A Case Report

Imperia System Delivery of Allegra Bioprosthetic Valve Maintains Safety, Efficacy at 1-Year in EMPIRE I Study

Quality-of-Life Improvements Are Associated With Reduced Risk of Death and Hospitalization in Patients With AF

COAPT Can Predict Treatment Effects in Real-World Secondary M-TEER Population: Registry Analysis

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Marketplace

FDA gives greenlight to new AI tool for managing heart failure patients

Explore the Site

Stay Connected